维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="TASSOPOULOS N"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Long - term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HbeAg negative chronic hepatitis B: results after 5 years of therapy显示文摘	Hadziyannis S Tassopoulos N Chang TT	2005	Hepatology2005，42，1：	1
2	Three-year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B patients in a long-term safety and efficacy study显示文摘	HADZIYANNIS S TASSOPOULOS N CHANG TT	2004	J Hepatol2004，42，1：	1
3	Long-term therapy with adefovir dipivoxil for HBeAg-nega- rive chronic hepatitis B for up to 5 years 显示文摘	Hadziyannis S J Tassopoulos N C Heathcote E J	2006	Gastroenterol- ogy2006，131，6：	1
4	Long-term therapy with adefovir dipivoxil for HBeAg-nega- tive chronic hepatitis B 显示文摘	Hadziyannis S J Tassopoulos N C Heathcote E J	2005	N Engl J Med2005，352，26：	1
5	Adefovir dipivoxil for the treatment of hepatitis B e antigen- negative chronic hepatitis B显示文摘	Hadziyannis S J Tassopoulos N C Heathcote E J	2003	N Engl J Med2003，348，9：	1
6	An epidemic of hepatitis A in an institution for young children 显示文摘	Tassopoulos N C Roumeliotou-Karayannis A Sakka M	1987	Am J Epidemiol1987，125，2：	1
7	Adefovir dipivoxil for the treatment of hepatitis B e antigennegative chronic hepatitis B显示文摘	Hadziyannis S J Tassopoulos N C Heathcote E J	2003	N Eng J Med2003，348，：	1
8	Three year study of adefovir dipivoxil(ADV )demonstrates sustained efficacy in pres- umed preeore muta chronic hepatitis B patients in a long-term safety and eficacy study显示文摘	Hadziyarmis S Tassopoulos N Chang TF	2004	Hepatology2004，40，1：	1
9	Long-term therapy with adefovir dipivoxil for HBeAg-negative chronichepatitis B 显示文摘	Hadziyannis S J Tassopoulos N C Heat hcote E J	2005	N Engl J Med2005，352，26：	1
10	Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen-negative Chronic Hepatitis B显示文摘	Hadziyannis S J Tassopoulos N C Heathcote E J	2003	N Engl J Med2003，348，9：	1
11	Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B:Results after 5 years of therapy显示文摘	Hadziyannis S Tassopoulos N Chang TT	2005	Hepatology2005，42，1：	1
12	Long-term therapy with adefovir dipivoxil forHBeAg-negative chronic hepatitis B显示文摘	Hadziyannis S J Tassopoulos N C Heathcote E J	2005	New England Journal of Medicine2005，352，26：	1
13	Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen-negative Chronic Hepatitis B显示文摘	Hadziyannis S J Tassopoulos N C Heathcote E J	2003	N Engl J Med2003，348，9：	1
14	Ealtecavir issuperior in treating patients with chronic hepatitis B who trove failed lamivudine therapy 显示文摘	Tassopoulos N Hadziyannis S Ciancian J	2004	Hepatology2004，，：	1
15	Enlecavir is superior in treating patients with chronic hepatitis B who have failed lamivudine therapy显示文摘	Tassopoulos N Hadziyaonis S Ciancian J	2004	Hepatology2004，40，14：	1
16	Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years显示文摘	Hadziyannis S Tassopoulos N Heathcote E	2006	Gastroenterology2006，131，：	1
17	Enlecavir is superior in treating patients with chrnnic hepatitis B who have failed lamivudine therapy显示文摘	Tassopoulos N Hadziyaonis S Ciancian J	2004	Hepatology2004，40，14：	1
18	Long-term therapy with ladefovir-dipivoxil for HBeAg-negative chronic hepatitis B显示文摘	Hadziyalnnis S J Tassopoulos N C Heatllcote E J		0，，26：	1
19	Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B显示文摘	RIZZETTO M TASSOPOULOS N C GOLDIN R D	2005	J Hepatol2005，42，2：	1
20	Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B显示文摘	HADZIYANNIS S J TASSOPOULOS N C HEATHCOTE E J	2003	N Engl J Med2003，348，9：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示